Effect of Ozanimod on Fecal Calprotectin and Fecal Lactoferrin, Biomarkers of Intestinal Inflammation, in the Phase 2 Touchstone Study of Patients With Moderate-to-severe Ulcerative Colitis
Year: 2021
Type: conference-abstract
Source: Inflammatory Bowel Diseases
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4230878455
